The dystroglycan receptor maintains glioma stem cells in the vascular niche
Autor: | Courtney L.R. Jurd, Kathleen S. Ensbey, Thomas Robertson, Zara C. Bruce, Paul R. Jamieson, Carolin Offenhäuser, Rochelle C.J. D’Souza, Bryan W. Day, Fiona M. Smith, Andrew W. Boyd, Po Inglis, Rosalind L. Jeffree, Kevin P. Campbell, Seckin Akgul, Yuchen Li, Justin D. Lathia, Zarnie Lwin, Yi Chieh Lim, Jeremy N. Rich, Terrance Grant Johns, Brett W. Stringer, Krishna P.L. Bhat, Ulrich Baumgartner |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2019 |
Předmět: |
0301 basic medicine
animal structures Central nervous system EphA3 Mice SCID Biology Pathology and Forensic Medicine Extracellular matrix 03 medical and health sciences Cellular and Molecular Neuroscience 0302 clinical medicine Mice Inbred NOD Glioma Glioblastoma (GBM) Glioma stem cell (GSC) commitment medicine Dystroglycan Tumor Microenvironment Compartment (development) Animals Humans Integrin-α6 Receptor Dystroglycans Extracellular Signal-Regulated MAP Kinases Cells Cultured Original Paper Brain Neoplasms Dystroglycan (DG) medicine.disease Cell biology 030104 developmental biology medicine.anatomical_structure Cell Transformation Neoplastic MAPK signalling biology.protein Perivascular niche Neoplastic Stem Cells Female Neurology (clinical) Stem cell Antibody MES-like GBM 030217 neurology & neurosurgery Neoplasm Transplantation |
Zdroj: | Acta Neuropathologica |
ISSN: | 1432-0533 0001-6322 |
Popis: | Glioblastomas (GBMs) are malignant central nervous system (CNS) neoplasms with a very poor prognosis. They display cellular hierarchies containing self-renewing tumourigenic glioma stem cells (GSCs) in a complex heterogeneous microenvironment. One proposed GSC niche is the extracellular matrix (ECM)-rich perivascular bed of the tumour. Here, we report that the ECM binding dystroglycan (DG) receptor is expressed and functionally glycosylated on GSCs residing in the perivascular niche. Glycosylated αDG is highly expressed and functional on the most aggressive mesenchymal-like (MES-like) GBM tumour compartment. Furthermore, we found that DG acts to maintain an MES-like state via tight control of MAPK activation. Antibody-based blockade of αDG induces robust ERK-mediated differentiation leading to reduced GSC potential. DG was shown to be required for tumour initiation in MES-like GBM, with constitutive loss significantly delaying or preventing tumourigenic potential in-vivo. These findings reveal a central role of the DG receptor, not only as a structural element, but also as a critical factor promoting MES-like GBM and the maintenance of GSCs residing in the perivascular niche. Electronic supplementary material The online version of this article (10.1007/s00401-019-02069-x) contains supplementary material, which is available to authorized users. |
Databáze: | OpenAIRE |
Externí odkaz: |